Team:Imperial College London/M2/EncapsulationRationale

From 2009.igem.org

(Difference between revisions)
(40pxModule 2 - Acid Resistance Overview)
(Phase 2:)
 
(2 intermediate revisions not shown)
Line 4: Line 4:
[[Image:II09_TimelineM2.png |center| 600px]]
[[Image:II09_TimelineM2.png |center| 600px]]
-
 
-
==<b>The need for encapsulation:</b>==
 
-
 
-
While <i>E.coli</i> has endogenous acid resistance pathways, colonisation of the gut is based on a "numbers approach". In essence, the majority of <i>E.coli</i> cells in a population do not survive passage through the stomach but the few that do are able to regenerate the population once in the intestine.
 
-
 
-
This point is illustrated by the experiment shown below:
 
-
 
-
[[Image:AcidBath.png|left|150px]]
 
-
 
-
Constitutive GFP producing <i>E.coli</i> cells were exposed to differing concentrations of acid for 30 minutes. The reduction in fluoresence is indicative of cell lysis and the subsequent acid-induced denaturing of GFP.
 
-
 
-
 
-
 
-
 
-
 
-
 
-
 
-
 
-
To tackle this seemingly insurmountable problem we adopted a two phase approach.
 
-
 
-
<b>Phase 1:</b> Identify a suitable chassis with the genotypic potential for acid–resistance.
 
-
 
-
<b>Phase 2:</b>Manipulate endogenous acid resistance pathways to control the acid resistant phenotype.
 
{{Imperial/09/Division}}
{{Imperial/09/Division}}
-
==<b>Phase 1:</b>==
 
-
 
-
Our rationale for looking for natural sources of acid resistance is that it is easier to hack existing pathways than to transfer large numbers of genes into a different chassis with a dissimilar genetic background.
 
-
 
-
Based on natural sources of acid resistance, <i>Lactobacillus</i>, <i>E.coli</i> and <i>B.subtilis</i> were shortlisted as potential chassis.
 
-
 
-
Of these three organisms, <i>E.coli</i> was chosen as it is safe, easy to work with and possesses a broad range of acid resistance strategies.
 
-
 
-
 
-
 
-
 
-
{{Imperial/09/Division}}
 
-
 
-
==<b>Phase 2:</b>==
 
-
 
-
 
-
We hacked E.coli’s acid resistance module in three places to achieve the production of a safe acid resistant capsule.
 
-
 
-
<b>Acid Resistant Polymer – Colanic acid:</b>
 
-
E.coli naturally produces a harmless acid–resistant polymer known as colanic acid. Colanic acid is a polymer of glucose, galactose and glucuronic acid. By tapping into the pathway that initiates colanic acid biosynthesis, we can turn on its production via the modulation of a transcription factor encoded by a gene called RcsB.
 
-
 
-
<html><a href="https://2009.igem.org/Team:Imperial_College_London/M2/genes"><img width=50px src="http://i691.photobucket.com/albums/vv271/dk806/II09_Learnmore.png" align="left"></a></html>&nbsp;<b><i>About RcsB</i></b>
 
-
 
-
 
-
<b>Safety  – Biofilm prevention:</b>
 
-
In nature, colanic acid acts as a binding agent between individual cells over which a biofilm can be formed. While colanic acid itself is harmless, biofilm formation is associated with a number of virulence factors. To prevent biofilm formation from occurring, we have tapped into a second pathway such that our cells become locked into colanic acid production. The gene responsible for preventing biofilm formation is a transcription factor encoded by a gene called YgiV.
 
-
 
-
<html><a href="https://2009.igem.org/Team:Imperial_College_London/M2/YgiV"><img width=50px src="http://i691.photobucket.com/albums/vv271/dk806/II09_Learnmore.png" align="left"></a></html>&nbsp; <b><i>About YgiV</i></b>
 
-
 
-
 
-
<b>Microencapsulation – Colanic acid tethering:</b>
 
-
In nature, colanic acid is associated with but not attached to the cell surface. To facilitate whole cell encapsulation, we have modified a third pathway to fix the colanic acid to the surface of the cell. This involves the over–production of an enzyme called Rfal.
 
-
<html><a href="https://2009.igem.org/Team:Imperial_College_London/M2/Rfal"><img width=50px src="http://i691.photobucket.com/albums/vv271/dk806/II09_Learnmore.png" align="left"></a></html>&nbsp; <b><i>About Rfal</i></b>
 

Latest revision as of 21:44, 19 October 2009

II09 Thumb m2.pngModule 2 - Acid Resistance Overview

II09 TimelineM2.png





Mr. Gene   Geneart   Clontech   Giant Microbes